{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T23:44:02Z","timestamp":1773445442193,"version":"3.50.1"},"reference-count":34,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T00:00:00Z","timestamp":1614729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Japanese Ministry of Health and Welfare","award":["36"],"award-info":[{"award-number":["36"]}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["16ek0109028h0003"],"award-info":[{"award-number":["16ek0109028h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18K07414"],"award-info":[{"award-number":["18K07414"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19K012202"],"award-info":[{"award-number":["19K012202"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Xeroderma pigmentosum complementation group D (XPD) is a UV-sensitive syndrome and a rare incurable genetic disease which is caused by the genetic mutation of the excision repair cross-complementation group 2 gene (ERCC2). Patients who harbor only XPD R683W mutant protein develop severe photosensitivity and progressive neurological symptoms. Cultured cells derived from patients with XPD (XPD R683W cells) demonstrate a reduced nucleotide excision repair (NER) ability. We hope to ameliorate clinical symptoms if we can identify candidate agents that would aid recovery of the cells\u2019 NER ability. To investigate such candidates, we created in silico methods of drug repurposing (in silico DR), a strategy that utilizes the recovery of ATP-binding in the XPD R683W protein after the induced fit. We chose 4E1RCat and aprepitant as the candidates for our in silico DR, and evaluated them by using the UV-induced unscheduled DNA synthesis (UDS) assay to verify the recovery of NER in XPD R683W cells. UDS values of the cells improved about 1.4\u20131.7 times after 4E1RCat treatment compared with solvent-only controls; aprepitant showed no positive effect. In this study, therefore, we succeeded in finding the candidate agent 4E1RCat for XPD R683W. We also demonstrated that our in silico DR method is a cost-effective approach for drug candidate discovery.<\/jats:p>","DOI":"10.3390\/biomedicines9030249","type":"journal-article","created":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T20:33:57Z","timestamp":1614803637000},"page":"249","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["In Silico Drug Repurposing by Structural Alteration after Induced Fit: Discovery of a Candidate Agent for Recovery of Nucleotide Excision Repair in Xeroderma Pigmentosum Group D Mutant (R683W)"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7568-8135","authenticated-orcid":false,"given":"Yutaka","family":"Takaoka","sequence":"first","affiliation":[{"name":"Division of Medical Informatics and Bioinformatics, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Ohta","sequence":"additional","affiliation":[{"name":"Division of Medical Informatics and Bioinformatics, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan"},{"name":"Department of Health Science, Kobe Tokiwa University, Kobe 653-0838, Japan"},{"name":"Division of Dermatology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Tateishi","sequence":"additional","affiliation":[{"name":"Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto 860-0811, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aki","family":"Sugano","sequence":"additional","affiliation":[{"name":"Division of Medical Informatics and Bioinformatics, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7632-8182","authenticated-orcid":false,"given":"Eiji","family":"Nakano","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Miura","sequence":"additional","affiliation":[{"name":"Division of Medical Informatics and Bioinformatics, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Division of Medical Informatics and Bioinformatics, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan"},{"name":"Department of Health Science, Kobe Tokiwa University, Kobe 653-0838, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikako","family":"Nishigori","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,3,3]]},"reference":[{"key":"ref_1","first-page":"1267","article-title":"UVs syndrome, a new general category of photosensitive disorder with defective DNA repair, is distinct from xeroderma pigmentosum variant and rodent complementation group I","volume":"56","author":"Itoh","year":"1995","journal-title":"Am. J. Hum. Genet."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/php.13052","article-title":"Characteristics of xeroderma pigmentosum in Japan: Lessons from two clinical surveys and measures for patient care","volume":"95","author":"Nishigori","year":"2019","journal-title":"Photochem. Photobiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1136\/jmg.2010.083022","article-title":"Cancer and neurologic degeneration in xeroderma pigmentosum: Long term follow-up characterises the role of DNA repair","volume":"48","author":"Bradford","year":"2011","journal-title":"J. Med. Genet."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archderm.1987.01660260111026","article-title":"Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases","volume":"123","author":"Kraemer","year":"1987","journal-title":"Arch. Dermatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"E1236","DOI":"10.1073\/pnas.1519444113","article-title":"Deep phenotyping of 89 xeroderma pigmentosum patients reveals unexpected heterogeneity dependent on the precise molecular defect","volume":"113","author":"Fassihi","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1034\/j.1600-0781.2001.017002047.x","article-title":"Xeroderma pigmentosum-bridging a gap between clinic and laboratory","volume":"17","author":"Moriwaki","year":"2001","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"key":"ref_7","first-page":"5656","article-title":"Defects in the DNA repair and transcription gene ERCC2 in the cancer-prone disorder xeroderma pigmentosum group D","volume":"55","author":"Takayama","year":"1995","journal-title":"Cancer Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.dnarep.2016.05.019","article-title":"Role of XPD in cellular functions: To TFIIH and beyond","volume":"44","author":"Houten","year":"2016","journal-title":"DNA Repair Amst."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1038\/jid.2014.14","article-title":"Differences in clinical phenotype among patients with XP complementation group D: 3D structure and ATP-docking of XPD in silico","volume":"134","author":"Nakano","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/978-1-60761-839-3_12","article-title":"De novo drug design","volume":"672","author":"Hartenfeller","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: Identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_12","first-page":"39","article-title":"In silico drug repositioning for treatment of xeroderma pigmentosum group D","volume":"3","author":"Takaoka","year":"2018","journal-title":"HPCI Res. Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1093\/nar\/gkp023","article-title":"A rapid non-radioactive technique for measurement of repair synthesis in primary human fibroblasts by incorporation of ethynyl deoxyuridine (EdU)","volume":"37","author":"Limsirichaikul","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"ref_14","unstructured":"(2017, November 16). PyMOL by Schr\u00f6dinger. Available online: https:\/\/pymol.org\/2\/."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1063\/1.448118","article-title":"Molecular dynamics with coupling to an external bath","volume":"81","author":"Berendsen","year":"1984","journal-title":"J. Chem. Phys."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","article-title":"LINCS: A linear constraint solver for molecular simulations","volume":"18","author":"Hess","year":"1997","journal-title":"J. Comput. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1107\/S0021889892009944","article-title":"PROCHECK: A program to check the stereochemical quality of protein structures","volume":"26","author":"Laskowski","year":"1993","journal-title":"J. Appl. Cryst."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.dnarep.2011.04.028","article-title":"XPB and XPD helicases in TFIIH orchestrate DNA duplex opening and damage verification to coordinate repair with transcription and cell cycle via CAK kinase","volume":"10","author":"Fuss","year":"2011","journal-title":"DNA Repair Amst."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s00280-016-3021-y","article-title":"Analysis of a single-codon E746 deletion in exon 19 of the epidermal growth factor receptor","volume":"77","author":"Ogasawara","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"10037","DOI":"10.1073\/pnas.181342398","article-title":"Electrostatics of nanosystems: Application to microtubules and the ribosome","volume":"98","author":"Baker","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1073\/pnas.1011477108","article-title":"Reversing chemoresistance by small molecule inhibition of the translation initiation complex eIF4F","volume":"108","author":"Cencic","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bcmd.2016.01.006","article-title":"Substance P enhances tissue factor release from granulocyte-macrophage colony-stimulating factor-dependent macrophages via the p22phox\/\u03b2-arrestin 2\/Rho A signaling pathway","volume":"57","author":"Yamaguchi","year":"2016","journal-title":"Blood Cells Mol. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10637-009-9218-8","article-title":"The NK-1 receptor antagonist aprepitant as a broad spectrum antitumor drug","volume":"28","author":"Munoz","year":"2010","journal-title":"Investig. New Drugs"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/ng.2229","article-title":"Mutations in UVSSA cause UV-sensitive syndrome and impair RNA polymerase IIo processing in transcription-coupled nucleotide-excision repair","volume":"44","author":"Nakazawa","year":"2012","journal-title":"Nat. Genet."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/1523-1747.ep12363303","article-title":"A simple method for diagnosing xeroderma pigmentosum variant","volume":"107","author":"Itoh","year":"1996","journal-title":"J. Investig. Derm."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Soni, S., Tyagi, C., Grover, A., and Goswami, S.K. (2014). Molecular modeling and molecular dynamics simulations based structural analysis of the SG2NA protein variants. BMC Res. Notes, 7.","DOI":"10.1186\/1756-0500-7-446"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/imcb.12010","article-title":"Osteopontin contributes to effective neutrophil recruitment, IL-1\u03b2 production and apoptosis in Aspergillus fumigatus keratitis","volume":"96","author":"Zhao","year":"2018","journal-title":"Immunol. Cell Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"947","DOI":"10.3389\/fimmu.2017.00947","article-title":"MicroRNA-21: A positive regulator for optimal production of type I and type III interferon by plasmacytoid dendritic cells","volume":"8","author":"Liu","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"6381","DOI":"10.1128\/JVI.00078-11","article-title":"Blocking eIF4E-eIF4G interaction as a strategy to impair coronavirus replication","volume":"85","author":"Cencic","year":"2011","journal-title":"J. Virol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Jeeva, S., Cheng, E., Ganaie, S.S., and Mir, M.A. (2017). Crimean-Congo hemorrhagic fever virus nucleocapsid protein augments mRNA translation. J. Virol., 91.","DOI":"10.1128\/JVI.00636-17"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Kolupaeva, V., Katsara, O., and Attur, M. (2019, January 2\u20135). Translational control maintains cartilage homeostasis and regulates osteoarthritis progression. Proceedings of the OARSI World Congress on Osteoarthritis: Promoting Clinical and Basic Research in Osteoarthritis, Toronto, ON, Canada.","DOI":"10.1016\/j.joca.2019.02.284"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/3\/249\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:32:05Z","timestamp":1760160725000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/3\/249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,3]]},"references-count":34,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3]]}},"alternative-id":["biomedicines9030249"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines9030249","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,3]]}}}